Advertisement

B Cell Lineage Contributions to Antiviral Host Responses

  • N. Baumgarth
  • Y. S. Choi
  • K. Rothaeusler
  • Y. Yang
  • L. A. Herzenberg
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 319)

Abstract

B cell responses are a major immune protective mechanism induced against a large variety of pathogens. Technical advances over the last decade, particularly in the isolation and characterization of B cell subsets by multicolor flow cytometry, have demonstrated the multifaceted nature of pathogen-induced B cell responses. In addition to participation by the major follicular B cell population, three B cell subsets are now recognized as key contributors to pathogen-induced host defenses: marginal zone (MZ) B cells, B-1a and B-1b cells. Each of these subsets seems to require unique activation signals and to react with distinct response patterns. Here we provide a brief review of the main developmental and functional features of these B cell subsets. Furthermore, we outline our current understanding of how each subset contributes to the humoral response to influenza virus infection and what regulates their differential responses. Understanding of the multilayered nature of the humoral responses to infectious agents and the complex innate immune signals that shape pathogen-specific humoral responses are likely at the heart of enhancing our ability to induce appropriate and long-lasting humoral responses for prophylaxis and therapy.

Keywords

Influenza Virus Marginal Zone Influenza Virus Infection Natural Antibody Innate Immune Signal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

BCR

B cell receptor

d.p.c

Days postconception

MZ

Marginal zone

TNP

Trinitrophenyl

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alugupalli KR, Leong JM, Woodland RT, Muramatsu M, Honjo T, Gerstein RM (2004) B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity 21:379–390.PubMedCrossRefGoogle Scholar
  2. Ansel KM, Harris RB, Cyster JG (2002) CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 16:67–76.PubMedCrossRefGoogle Scholar
  3. Attanavanich K, Kearney JF (2004) Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 172:803–811.PubMedGoogle Scholar
  4. Bachmann MF, Zinkernagel RM (1997) Neutralizing antiviral B cell responses. Annu Rev Immunol 15:235–270.PubMedCrossRefGoogle Scholar
  5. Basler CF, Reid AH, Dybing JK, Janczewski TA, Fanning TG, Zheng H et al (2001) From the cover: sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc Natl Acad Sci U S A 98:2746–2751.PubMedCrossRefGoogle Scholar
  6. Baumgarth N (2000) A two-phase model of B-cell activation. Immunol Rev 176:171–180.PubMedCrossRefGoogle Scholar
  7. Baumgarth N (2004) B-cell immunophenotyping. Methods Cell Biol 75:643–662.PubMedCrossRefGoogle Scholar
  8. Baumgarth N, Kelso A (1996) In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J Virol 70:4411–4418.PubMedGoogle Scholar
  9. Baumgarth N, Herman OC, Jager GC, Brown L, Herzenberg LA, Herzenberg LA (1999) Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci U S A 96:2250–2255.PubMedCrossRefGoogle Scholar
  10. Baumgarth N, Chen J, Herman OC, Jager GC, Herzenberg LA (2000a) The role of B-1 and B-2 cells in immune protection from influenza virus infection. Curr Top Microbiol Immunol 252:163–169.PubMedGoogle Scholar
  11. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J (2000b) B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 192:271–280.PubMedCrossRefGoogle Scholar
  12. Baumgarth N, Tung JW, Herzenberg LA (2005) Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol 26:347–362.PubMedCrossRefGoogle Scholar
  13. Berland R, Wortis HH (2002) Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 20:253–300.PubMedCrossRefGoogle Scholar
  14. Bernard A, Coitot S, Bremont A, Bernard G (2005) T and B cell cooperation: a dance of life and death. Transplantation 79:S8–S11.PubMedCrossRefGoogle Scholar
  15. Bikah G, Carey J, Ciallella JR, Tarakhovsky A, Bondada S (1996) CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 274:1906–1909.PubMedCrossRefGoogle Scholar
  16. Boes M, Esau C, Fischer MB, Schmidt T, Carroll M, Chen J (1998a) Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol 160:4776–4787.PubMedGoogle Scholar
  17. Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J (1998b) A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 188:2381–2386.PubMedCrossRefGoogle Scholar
  18. Bridges CB, Fukuda K, Cox NJ, Singleton JA (2001) Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 50:1–44.Google Scholar
  19. Carvalho TL, Mota-Santos T, Cumano A, Demengeot J, Vieira P (2001) Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7(-/)- mice. J Exp Med 194:1141–1150.PubMedCrossRefGoogle Scholar
  20. Chang WLW, Coro ES, Rau FC, Xiao Y, Erle DJ, Baumgarth N (2007) Influenza virus infection causes global respiratory tract B cell response modulation via innate immune signals. J Immunology 178:1457–1467.Google Scholar
  21. Cinamon G, Matloubian M, Lesneski MJ, Xu Y, Low C, Lu T et al (2004) Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat Immunol 5:713–720.PubMedCrossRefGoogle Scholar
  22. Coro ES, Chang WL, Baumgarth N (2006) Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J Immunol 176:4343–4351.PubMedGoogle Scholar
  23. Dammers PM, Kroese FG (2005) Recruitment and selection of marginal zone B cells is independent of exogenous antigens. Eur J Immunol 35:2089–2099.PubMedCrossRefGoogle Scholar
  24. Doherty PC (2000) Accessing complexity: the dynamics of virus-specific T cell responses. Annu Rev Immunol 18:561–592.PubMedCrossRefGoogle Scholar
  25. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, Stevenson PG (1997) Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 159:105–117.PubMedCrossRefGoogle Scholar
  26. Ferguson AR, Youd ME, Corley RB (2004) Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. Int Immunol 16:1411–1422.PubMedCrossRefGoogle Scholar
  27. Fink K, Lang KS, Manjarrez-Orduno N, Junt T, Senn BM, Holdener M et al (2006) Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses. Eur J Immunol 36:2094–2105.PubMedCrossRefGoogle Scholar
  28. Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, Doherty PC (1998) Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8:683–691.PubMedCrossRefGoogle Scholar
  29. Forster I, Rajewsky K (1990) The bulk of the peripheral B-cell pool in mice is stable and not rapidly renewed from the bone marrow. Proc Natl Acad Sci U S A 87:4781–4784.PubMedCrossRefGoogle Scholar
  30. Fujisawa H, Tsuru S, Rtaniguchi M, Zinnaka Y, Nomoto K (1987) Protective mechanisms against pulmonary infection with influenza virus. I. Relative contribution of polymorphonuclear leukocytes and of alveolar macrophages to protection during the early phase of intranasal infection. J Gen Virol 68:425–432.PubMedCrossRefGoogle Scholar
  31. Garcia-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, Durbin JE (1998) The role of interferon in influenza virus tissue tropism. J Virol 72:8550–8558.PubMedGoogle Scholar
  32. Gerhard W, Mozdzanowska K, Furchner M, Washko G, Maiese K (1997) Role of the B-cell response in recover o mice from primary influenza virus infection. Immunol Rev 159:95–103.PubMedCrossRefGoogle Scholar
  33. Godin IE, Garcia-Porrero JA, Coutinho A, Dieterlen-Lievre F, Marcos MA (1993) Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors. Nature 364:67–70.PubMedCrossRefGoogle Scholar
  34. Goodnow CC, Cyster JG, Hartley SB, Bell SE, Cooke MP, Healy JI et al (1995) Self-tolerance checkpoints in B lymphocyte development. Adv Immunol 59:279–368.PubMedCrossRefGoogle Scholar
  35. Ha SA, Tsuji M, Suzuki K, Meek B, Yasuda N, Kaisho T, Fagarasan S (2006) Regulation of B1 cell migration by signals through Toll-like receptors. J Exp Med 203:2541–2550.PubMedCrossRefGoogle Scholar
  36. Haas KM, Poe JC, Steeber DA, Tedder TF (2005) B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23:7–18.PubMedCrossRefGoogle Scholar
  37. Hao Z, Rajewsky K (2001) Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J Exp Med 194:1151–1164.PubMedCrossRefGoogle Scholar
  38. Hardy RR, Hayakawa K (1991) A developmental switch in B lymphopoiesis. Proc Natl Acad Sci U S A 88:11550–11554.PubMedCrossRefGoogle Scholar
  39. Hardy RR, Hayakawa K (2001) B cell development pathways. Annu Rev Immunol 19:595–621.PubMedCrossRefGoogle Scholar
  40. Hayakawa K, Hardy RR, Herzenberg LA, Herzenberg LA (1985) Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med 161:1554–1568.PubMedCrossRefGoogle Scholar
  41. Heer AK, Shamshiev A, Donda A, Uematsu S, Akira S, Kopf M, Marsland BJ (2007) TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J Immunol 178:2182–2191.PubMedGoogle Scholar
  42. Heltemes-Harris L, Liu X, Manser T (2005) An antibody VH gene that promotes marginal zone B cell development and heavy chain allelic inclusion. Int Immunol 17:1447–1461.PubMedCrossRefGoogle Scholar
  43. Herzenberg LA, Stall AM, Lalor PA, Sidman C, Moore WA, Parks DR (1986) The Ly-1 B cell lineage. Immunol Rev 93:81–102.PubMedCrossRefGoogle Scholar
  44. Herzenberg LA, Kantor AB, Herzenberg LA (1992) Layered evolution in the immune system. A model for the ontogeny and development of multiple lymphocyte lineages. Ann N Y Acad Sci 651:1–9.PubMedCrossRefGoogle Scholar
  45. Herzenberg LA, Tung JW (2006) B cell lineages: documented at last! Nat Immunol 7:225–226.PubMedCrossRefGoogle Scholar
  46. Hippen KL, Tze LE, Behrens TW (2000) CD5 maintains tolerance in anergic B cells. J Exp Med 191:883–890.PubMedCrossRefGoogle Scholar
  47. Hogan RJ, Usherwood EJ, Zhong W, Roberts AA, Dutton RW, Harmsen AG, Woodland DL (2001) Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J Immunol 166:1813–1822.PubMedGoogle Scholar
  48. Kaminski DA, Stavnezer J (2006) Enhanced IgA class switching in marginal zone and B1 B cells relative to follicular/B2 B cells. J Immunol 177:6025–6029.PubMedGoogle Scholar
  49. Kantor AB, Herzenberg LA (1993) Origin of murine B cell lineages. Annu Rev Immunol 11:501–538.PubMedCrossRefGoogle Scholar
  50. Kavaler J, Caton AJ, Staudt LM, Gerhard W (1991) A B cell population that dominates the primary response to influenza virus hemagglutinin does not participate in the memory response. Eur J Immunol 21:2687–2695.PubMedCrossRefGoogle Scholar
  51. Kantor AB, Stall AM, Adams S, Watanabe K, Herzenberg LA (1995) De novo development and self-replenishment of B cells. Int Immunol 7:55–68.PubMedCrossRefGoogle Scholar
  52. Kavaler J, Caton AJ, Staudt LM, Schwartz D, Gerhard W (1990) A set of closely related antibodies dominates the primary antibody response to the antigenic site CB of the A/PR/8/34 influenza virus hemagglutinin. J Immunol 145:2312–2321.PubMedGoogle Scholar
  53. Kawikova I, Paliwal V, Szczepanik M, Itakura A, Fukui M, Campos RA et al (2004) Airway hyper-reactivity mediated by B-1 cell immunoglobulin M antibody generating complement C5a at 1 day post-immunization in a murine hapten model of non-atopic asthma. Immunology 113:234–245.PubMedCrossRefGoogle Scholar
  54. Kenny JJ, Yaffe LJ, Ahmed A, Metcalf ES (1983) Contribution of Lyb 5+ and Lyb 5–B cells to the primary and secondary phosphocholine-specific antibody response. J Immunol 130:2574–2579.PubMedGoogle Scholar
  55. Kikuchi K, Kondo M (2006) Developmental switch of mouse hematopoietic stem cells from fetal to adult type occurs in bone marrow after birth. Proc Natl Acad Sci U S A 103:17852–17857.PubMedCrossRefGoogle Scholar
  56. Knoops L, Louahed J, Renauld JC (2004) IL-9-induced expansion of B-1b cells restores numbers but not function of B-1 lymphocytes in xid mice. J Immunol 172:6101–6106.PubMedGoogle Scholar
  57. Kraus M, Alimzhanov MB, Rajewsky N, Rajewsky K (2004) Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell 117:787–800.PubMedCrossRefGoogle Scholar
  58. Kroese FG, Butcher EC, Stall AM, Lalor PA, Adams S, Herzenberg LA (1989) Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int Immunol 1:75–84.PubMedCrossRefGoogle Scholar
  59. Lalor PA, Herzenberg LA, Adams S, Stall AM (1989a) Feedback regulation of murine Ly-1 B cell development. Eur J Immunol 19:507–513.PubMedCrossRefGoogle Scholar
  60. Lalor PA, Stall AM, Adams S, Herzenberg LA (1989b) Permanent alteration of the murine Ly-1 B repertoire due to selective depletion of Ly-1 B cells in neonatal animals. Eur J Immunol 19:501–506.PubMedCrossRefGoogle Scholar
  61. Le Bon A, Thompson C, Kamphuis E, Durand V, Rossmann C, Kalinke U, Tough DF (2006) Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J Immunol 176:2074–2078.PubMedGoogle Scholar
  62. Lewis GK, Goodman JW, Ranken R (1978) Activation of B cell subsets by T-dependent and T-independent antigens. Adv Exp Med Biol 98:339–356.PubMedGoogle Scholar
  63. Lopes-Carvalho T, Foote J, Kearney JF (2005) Marginal zone B cells in lymphocyte activation and regulation. Curr Opin Immunol 17:244–250.PubMedCrossRefGoogle Scholar
  64. Martin F, Oliver AM, Kearney JF (2001) Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14:617–629.PubMedCrossRefGoogle Scholar
  65. Meffre E, Casellas R, Nussenzweig MC (2000) Antibody regulation of B cell development. Nat Immunol 1:379–385.PubMedCrossRefGoogle Scholar
  66. Montecino-Rodriguez E, Leathers H, Dorshkind K (2006) Identification of a B-1 B cell-specified progenitor. Nat Immunol 7:293–301.PubMedCrossRefGoogle Scholar
  67. Mozdzanowska K, Furchner M, Maiese K, Gerhard W (1997) CD4+ T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells. Virology 239:217–225.PubMedCrossRefGoogle Scholar
  68. Mozdzanowska K, Maiese K, Gerhard W (2000) Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance. J Immunol 164:2635–2643.PubMedGoogle Scholar
  69. Murakami M, Tsubata T, Shinkura R, Nisitani S, Okamoto M, Yoshioka H et al (1994) Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J Exp Med 180:111–121.PubMedCrossRefGoogle Scholar
  70. Noelle RJ (1996) CD40 and its ligand in host defense. Immunity 4:415–419.PubMedCrossRefGoogle Scholar
  71. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H, Zinkernagel RM (1999) Control of early viral and bacterial distribution and disease by natural antibodies. Science 286:2156–2159.PubMedCrossRefGoogle Scholar
  72. Pasare C, Medzhitov R (2005) Control of B-cell responses by Toll-like receptors. Nature 438:364–368.PubMedCrossRefGoogle Scholar
  73. Paus D, Phan TG, Chan TD, Gardam S, Basten A, Brink R (2006) Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J Exp Med 203:1081–1091.PubMedCrossRefGoogle Scholar
  74. Pecquet SS, Ehrat C, Ernst PB (1992a) Enhancement of mucosal antibody responses toSalmonella typhimurium and the microbial hapten phosphorylcholine in mice with X-linked immunodeficiency by B-cell precursors from the peritoneal cavity. Infect Immun 60:503–509.PubMedGoogle Scholar
  75. Pecquet SS, Zazulak J, Simpson SD, Ernst PB (1992b) Reconstitution of xid mice with donor cells enriched for CD5+ B cells restores contrasuppression. Ann N Y Acad Sci 651:173–175.PubMedCrossRefGoogle Scholar
  76. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5 -phosphates. Science 314:997–1001.PubMedCrossRefGoogle Scholar
  77. Pillai S, Cariappa A, Moran ST (2005) Marginal zone B cells. Annu Rev Immunol 23:161–196.PubMedCrossRefGoogle Scholar
  78. Reading PC, Morey LS, Crouch EC, Anders EM (1997) Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol 71:8204–8212.PubMedGoogle Scholar
  79. Renegar KB, Small PA Jr (1991a) Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J Virol 65:2146–2148.PubMedGoogle Scholar
  80. Renegar KB, Small PA Jr (1991b) Passive transfer of local immunity to influenza virus infection by IgA antibody. J Immunol 146:1972–1978.PubMedGoogle Scholar
  81. Rolink AG, Schaniel C, Andersson J, Melchers F (2001) Selection events operating at various stages in B cell development. Curr Opin Immunol 13:202–207.PubMedCrossRefGoogle Scholar
  82. Ruprecht CR, Lanzavecchia A (2006) Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol 36:810–816.PubMedCrossRefGoogle Scholar
  83. Schmitz N, Kurrer M, Bachmann MF, Kopf M (2005) Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J Virol 79:6441–6448.PubMedCrossRefGoogle Scholar
  84. Sha Z, Compans RW (2000) Induction of CD4+ T-cell-independent immunoglobulin responses by inactivated influenza virus. J Virol 74:4999–5005.PubMedCrossRefGoogle Scholar
  85. Song H, Cerny J (2003) Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen. J Exp Med 198:1923–1935.PubMedCrossRefGoogle Scholar
  86. Stall AM, Adams S, Herzenberg LA, Kantor AB (1992) Characteristics and development of the murine B-1b (Ly-1 B sister) cell population. Ann N Y Acad Sci 651:33–43.PubMedCrossRefGoogle Scholar
  87. Szczepanik M, Akahira-Azuma M, Bryniarski K, Tsuji RF, Kawikova I, Ptak W et al (2003) B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity. J Immunol 171:6225–6235.PubMedGoogle Scholar
  88. Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, Garcia-Sastre A (2000) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74:7989–7996.PubMedCrossRefGoogle Scholar
  89. Tarlinton DM, McLean M, Nossal GJ (1995) B1 and B2 cells differ in their potential to switch immunoglobulin isotype. Eur J Immunol 25:3388–3393.PubMedCrossRefGoogle Scholar
  90. Virelizier JL, Postlethwaite R, Schild GC, Allison AC (1974) Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med 140:1559–1570.PubMedCrossRefGoogle Scholar
  91. Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, Garcia-Sastre A (2000) Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 74:11566–11573.PubMedCrossRefGoogle Scholar
  92. Wells SM, Kantor AB, Stall AM (1994) CD43 (S7) expression identifies peripheral B cell subsets. J Immunol 153:5503–5515.PubMedGoogle Scholar
  93. Yang Y, Tung JW, Ghosn EE, Herzenberg LA, Herzenberg LA (2007) Division and differentiation of natural antibody-producing cells in mouse spleen. Proc Natl Acad Sci U S A 104:4542–4546.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • N. Baumgarth
    • 1
  • Y. S. Choi
  • K. Rothaeusler
  • Y. Yang
  • L. A. Herzenberg
  1. 1.Center for Comparative MedicineUniversity of California, DavisDavisUSA

Personalised recommendations